CHI3L1 and non-small cell lung carcinoma: High CHI3L1 expression and serum levels have been found in both non-small-cell lung carcinoma (NSCLC) and small-cell lung carcinoma (SCLC) patients, and they have been linked to worse overall survival, [7] a poorer response to chemotherapy, and worse chemotherapy responses [8].